Form 4 Tracker
Beam Therapeutics Inc.
BEAM

36 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 2, 2025Oct 2 8:23 PMJOHN M EVANS
Proposed Sale
25,000$24.63$615.7K—

View →

Oct 1, 2025Oct 1 8:12 PMJOHN M EVANS
Proposed Sale
25,000$24.51$612.7K—

View →

Apr 2, 2025Apr 2 8:08 PMAMY SIMON
Proposed Sale
20,997$17.73$372.3K—

View →

Apr 1, 2025Mar 31 10:44 PMAMY SIMON
Proposed Sale
30,562$22.21$678.8K—

View →

Apr 1, 2025Mar 31 10:43 PMJOHN M. EVANS
Proposed Sale
64,842$22.21$1.4M—

View →

Apr 1, 2025Mar 31 10:43 PMCHRISTINE BELLON
Proposed Sale
18,125$22.21$402.6K—

View →

Apr 1, 2025Mar 31 10:43 PMGIUSEPPE CIARAMELLA
Proposed Sale
23,750$22.21$527.5K—

View →

Feb 14, 2025Feb 14 9:06 PMCHRISTINE BELLON
Proposed Sale
10,000$34.00$340.0K—

View →

Jan 30, 2025Jan 30 9:12 PMJOHN M EVANS
Proposed Sale
30,000$26.75$802.5K—

View →

Dec 31, 2024Dec 31 12:29 AMBETHANY J. CAVANAGH
Proposed Sale
9,500$25.27$240.1K—

View →

Dec 31, 2024Dec 31 12:26 AMCHRISTINE BELLON
Proposed Sale
4,167$25.27$105.3K—

View →

Oct 14, 2024Oct 15 3:37 PMGiuseppe Ciaramella
Proposed Sale
102,220$24.65$2.5M—

View →

Oct 7, 2024Oct 7 9:00 PMBurrell Terry-Ann
Proposed Sale
185,565$23.00$4.3M—

View →

Sep 30, 2024Sep 30 8:51 PMJOHN M EVANS
Proposed Sale
60,000$24.60$1.5M—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 29, 2026Feb 2 9:05 PMJohn M. EvansDirector, CEO
Option Exercise
25,000$0.6793,672(D)

View →

Jan 31, 2026Feb 2 9:05 PMAmy SimonChief Medical Officer
Grant/Award
88,500$27.6288,500(D)

View →

← Previous

Page 2 of 2